UA107920C2 - Substituted pyrimidine for the treatment of diseases such as cancer - Google Patents

Substituted pyrimidine for the treatment of diseases such as cancer

Info

Publication number
UA107920C2
UA107920C2 UAA201107743A UAA201107743A UA107920C2 UA 107920 C2 UA107920 C2 UA 107920C2 UA A201107743 A UAA201107743 A UA A201107743A UA A201107743 A UAA201107743 A UA A201107743A UA 107920 C2 UA107920 C2 UA 107920C2
Authority
UA
Ukraine
Prior art keywords
treatment
diseases
cancer
substituted pyrimidine
paragraph
Prior art date
Application number
UAA201107743A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Heinz Stadtmueller
Ioannis Sapountzis
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Priority claimed from PCT/EP2009/065768 external-priority patent/WO2010058032A2/en
Publication of UA107920C2 publication Critical patent/UA107920C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Abstract

У заявці описані сполуки загальної формули (1), (1)в якій значення А, В, X, R-Rвизначені у пункті 1 формули винаходу, які можуть бути застосовані для лікування захворювань, які характеризуються надмірною або аномальною проліферацією клітин, і їх застосування для приготування лікарського засобу, який має зазначені вище характеристики.The application describes compounds of General formula (1), (1) in which the values of A, B, X, R-R are defined in paragraph 1 of the claims, which can be used for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for the preparation of a medicinal product having the above characteristics.

UAA201107743A 2008-11-24 2009-11-24 Substituted pyrimidine for the treatment of diseases such as cancer UA107920C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08169807 2008-11-24
PCT/EP2009/065768 WO2010058032A2 (en) 2008-11-24 2009-11-24 New compounds

Publications (1)

Publication Number Publication Date
UA107920C2 true UA107920C2 (en) 2015-03-10

Family

ID=40612944

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201107743A UA107920C2 (en) 2008-11-24 2009-11-24 Substituted pyrimidine for the treatment of diseases such as cancer

Country Status (1)

Country Link
UA (1) UA107920C2 (en)

Similar Documents

Publication Publication Date Title
EA201100794A1 (en) SUBSTITUTED PYRIMIDINES INTENDED FOR THE TREATMENT OF DISEASES, SUCH AS CANCER
MA33939B1 (en) 5-alkynyl-PYRIMIDINE
EA201201661A1 (en) NEW AMINOPYRAZOLOHINAZOLINES
EA201101330A1 (en) SUBSTITUTED PYRIMIDINES INTENDED FOR CANCER TREATMENT
EA201000105A1 (en) CHEMICAL COMPOUNDS
EA201100564A1 (en) ANTIPROLIFERATIVE COMPOUNDS
MX343706B (en) Novel heterocyclic derivatives.
MX2013001970A (en) Pyrrolopyrimidine compounds and uses thereof.
EA201500536A1 (en) TRIAZOLOPIRAZIN
MX2013004491A (en) Boronates as arginase inhibitors.
EA201100255A1 (en) 5-Alkinylpyrimidines
EA201490493A1 (en) PIRANO [3,2-D] [1,3] TIAZOLE AS GLYOZIDASE INHIBITORS
BR112012029647A2 (en) new pyrimidine derivatives
MX2011012643A (en) 2, 4 -diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation.
EA201100254A1 (en) NEW CONNECTIONS
MY151342A (en) Phenylamino isonicotinamide compounds
MX2014014937A (en) Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-ben zooxazinyls as bace1 inhibitors.
WO2015042414A8 (en) Multicyclic compounds and methods of using same
EA201001427A1 (en) TIAZOLIDIGIDROIDAZOLE
TN2011000531A1 (en) 5- alkynyl - pyridines
WO2009151495A3 (en) Oxazole compounds, compositions and methods of use
EA201101537A1 (en) TIATRIASOCYCLOPENTAZULARS AS PI3-KINAZ INHIBITORS INTENDED FOR CANCER TREATMENT
TN2012000370A1 (en) 5-alkynyl pyrimidines and their use as kinase inhibitors
UA107920C2 (en) Substituted pyrimidine for the treatment of diseases such as cancer
TN2013000327A1 (en) Novel heterocyclic derivatives